Coffee consumption and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma by sex: The liver cancer pooling project

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 9, 2015, Pages 1398-1406

  Petrick, Jessica L ^a   Freedman, Neal D ^a   Graubard, Barry I ^a   Sahasrabuddhe, Vikrant V ^a   Lai, Gabriel Y ^a   Alavanja, Michael C ^a   Beane Freeman, Laura E ^a   Boggs, Deborah A ^b   Buring, Julie E ^c,d   Chan, Andrew T ^c,e   Chong, Dawn Q ^e   Fuchs, Charles S ^e   Gapstur, Susan M ^f   Gaziano, John Michael ^c   Giovannucci, Edward L ^d   Hollenbeck, Albert R ^g   King, Lindsay Y ^c,e   Koshiol, Jill ^a   Lee, I Min ^c,d   Linet, Martha S ^a   Palmer, Julie R ^b   Poynter, Jenny N ^h   Purdue, Mark P ⁱ   Robien, Kim ^j   Schairer, Catherine ^a   Sesso, Howard D ^c,d   Sigurdson, Alice J ^a   Zeleniuch Jacquotte, Anne ^k   Wactawski Wende, Jean ^l   Campbell, Peter T ^f   McGlynn, Katherine A ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f AMERICAN CANCER SOCIETY   (United States)

^g AARP   (United States)

^h UNIVERSITY OF MINNESOTA   (United States)

ⁱ ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^j GEORGE WASHINGTON UNIVERSITY   (United States)

^k NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY AT BUFFALO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; COFFEE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER PATIENT; CANCER RISK; COFFEE; COHORT ANALYSIS; FEMALE; FOLLOW UP; FOOD INTAKE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MIDDLE AGED; PRIORITY JOURNAL; RISK REDUCTION; TREND STUDY; UNITED STATES; BILE DUCT NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CHEMISTRY; CHOLANGIOCARCINOMA; DRINKING; INTRAHEPATIC BILE DUCT; LIVER NEOPLASMS; SEX DIFFERENCE;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CAFFEINE; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; COFFEE; DRINKING; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; SEX FACTORS; UNITED STATES;

EID: 84941798822     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0137     Document Type: Article

References (50)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013 [accessed 2014 June 2]. Available from: http://globocan.iarc.fr.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
3. Simard EP, Ward EM, Siegel R, Jemal A. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin 2012;62:118-28.
4. Altekruse SF, Henley SJ, Cucinelli JE, McGlynn KA. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol 2014;109:542-53.
5. McGlynn KA, Tarone RE, El-Serag HB. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev 2006;15: 1198-203.
6. Ambade A, Mandrekar P. Oxidative stress and inflammation: essential partners in alcoholic liver disease. Int J Hepatol 2012;2012: 853175.
7. Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol 2012;57:69-76.
8. Bravi F, Bosetti C, Tavani A, Gallus S, La Vecchia C. Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis. Clin Gastroenterol Hepatol 2013;11:1413-21 e1.
9. Saab S, Mallam D, Cox GA II, Tong MJ. Impact of coffee on liver diseases: a systematic review. Liver Int 2014;34:495-504.
10. Muriel P, Arauz J. Coffee and liver diseases. Fitoterapia 2010;81: 297-305.
11. Cadden IS, Partovi N, Yoshida EM. Review article: possible beneficial effects of coffee on liver disease and function. Aliment Pharmacol Ther 2007;26:1-8.
12. Ludwig IA, Clifford MN, Lean ME, Ashihara H, Crozier A. Coffee: biochemistry and potential impact on health. Food Funct 2014;5: 1695-717.
13. El-Serag HB, Kanwal F. Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology 2014;60: 1767-75.
14. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012;142:1264-73 e1.
15. Schliep KC, Schisterman EF, Mumford SL, Pollack AZ, Zhang C, Ye A, et al. Caffeinated beverage intake and reproductive hormones among premenopausal women in the BioCycle Study. Am J Clin Nutr 2012; 95:488-97.
16. Takahashi S, Saito K, Jia H, Kato H. An integrated multi-omics study revealed metabolic alterations underlying the effects of coffee consumption. PLoS ONE 2014;9:e91134.
17. Setiawan VW, Wilkens LR, Lu SC, Hernandez BY, Le Marchand L, Henderson BE. Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort. Gastroenterology 2015;148:118-25.
18. McGlynn KA, Sahasrabuddhe VV, Campbell PT, Graubard BI, Chen J, Schwartz LM, et al. Reproductive factors, exogenous hormone use and risk of liver cancer among U.S. women: results from the Liver Cancer Pooling Project. Br J Cancer 2015;112:1266-72.
19. Schatzkin A, Subar AF,Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, et al. Design and serendipity in establishing a large cohortwith wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 2001; 154:1119-25.
20. Alavanja MC, Sandler DP, McMaster SB, Zahm SH, McDonnell CJ, Lynch CF, et al. The Agricultural Health Study. Environ Health Perspect 1996; 104:362-9.
21. Boice JD Jr, Mandel JS, Doody MM, Yoder RC,McGowan R. A health survey of radiologic technologists. Cancer 1992;69:586-98.
22. Kramer BS, Gohagan J, Prorok PC, Smart C. A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers. Cancer 1993;71:589-93.
23. Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE. Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med 2000;9:19-27.
24. Calle EE, Rodriguez C, Jacobs EJ, Almon ML, Chao A,McCullough ML, et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer 2002;94: 2490-501.
25. Munger RG, Folsom AR, Kushi LH, Kaye SA, Sellers TA. Dietary assessment of older Iowa womenwith a food frequency questionnaire: nutrient intake, reproducibility, and comparison with 24-hour dietary recall interviews. Am J Epidemiol 1992;136:192-200.
26. Rosenberg L, Adams-Campbell L, Palmer JR. The Black Women's Health Study: a follow-up study for causes and preventions of illness. J Am Med Womens Assoc 1995;50:56-8.
27. Anderson GL, Manson J, Wallace R, Lund B, Hall D, Davis S, et al. Implementation of the Women's Health Initiative study design. Ann Epidemiol 2003;13:S5-17.
28. Kleinbaum D. Logistic regression: a self-learning text second ed. New York: Springer; 2002.
29. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008.
30. Kleinbaum DG, Klein M. Survival analysis: a self-learning text. 3rd ed. New York: Springer; 2012.
31. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
32. Lai GY, Weinstein SJ, Albanes D, Taylor PR, McGlynn KA, Virtamo J, et al. The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers. Br J Cancer 2013;109: 1344-51.
33. Bamia C, Lagiou P, Jenab M, Trichopoulou A, Fedirko V, Aleksandrova K, et al. Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: multicentre, prospective cohort study. Int J Cancer 2015;136:1899-908.
34. InoueM, Kurahashi N, Iwasaki M, Shimazu T, Tanaka Y, Mizokami M, et al. Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Cancer Epidemiol Biomarkers Prev 2009;18:1746-53.
35. Gallus S, BertuzziM, Tavani A, Bosetti C, Negri E, La Vecchia C, et al. Does coffee protect against hepatocellular carcinoma? Br J Cancer 2002;87: 956-9.
36. Inoue M, Yoshimi I, Sobue T, Tsugane S, Group JS. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 2005;97:293-300.
37. Kurozawa Y, Ogimoto I, Shibata A, Nose T, Yoshimura T, Suzuki H, et al. Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer 2005;93:607-10.
38. Shimazu T, Tsubono Y, Kuriyama S, Ohmori K, Koizumi Y, Nishino Y, et al. Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Cancer 2005;116: 150-4.
39. Hawkins DI, Roupe D, Coney KA. The influence of geographic subcultures in the United States. Advances in Consumer Research 1981;8: 713-7.
40. Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 2002;40:1155-63.
41. Urgert R, Vanderweg G, Kosmeijerschuil TG, Vandebovenkamp P, Hovenier R, Katan MB. Levels of the cholesterol-elevating diterpenes cafestol and kahweol in various coffee brews. J Agric Food Chem 1995;43:2167-72.
42. Renouf M, Marmet C, Guy P, Fraering AL, Longet K, Moulin J, et al. Nondairy creamer, but not milk, delays the appearance of coffee phenolic acid equivalents in human plasma. J Nutr 2010;140:259-63.
43. DuarteGS, Farah A. Effect of simultaneous consumption ofmilk and coffee on chlorogenic acids' bioavailability in humans (vol 59, 7925, 2011). J Agric Food Chem 2011;59:10772-.
44. Spiller MA. The chemical components of coffee. In:Spiller GA, editor. Caffeine. Boca Raton, FL: CRC Press; 1998.
45. Stalder R, Bexter A, Wurzner HP, Luginbuhl H. A carcinogenicity study of instant coffee in Swiss mice. Food Chem Toxicol 1990;28: 829-37.
46. BoettlerU, Volz N, Pahlke G, Teller N, Kotyczka C, Somoza V, et al. Coffees rich in chlorogenic acid or N-methylpyridinium induce chemopreventive phase II-enzymes via the Nrf2/ARE pathway in vitro and in vivo. Mol Nutr Food Res 2011;55:798-802.
47. Heckman MA, Weil J, Gonzalez de Mejia E. Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci 2010;75: R77-87.
48. Fon Sing M, Yang WS, Gao S, Gao J, Xiang YB. Epidemiological studies of the association between tea drinking and primary liver cancer: a metaanalysis. Eur J Cancer Prev 2011;20:157-65.
49. Soroko S, Chang J, Barrett-Connor E. Reasons for changing caffeinated coffee consumption: the Rancho Bernardo Study. J Am Coll Nutr 1996;15:97-101.
50. Kamath S, Lip GY. Fibrinogen: biochemistry, epidemiology and determinants. QJM 2003;96:711-29.